RBC Europe’s Sanofi SNY Stock Holding History

RBC Europe’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-141	Closed	-$6.8K	–	1070
2021 Q3	$6.8K	Hold	141	–	–	﹤0.01%	1005
2021 Q2	$7.42K	Hold	141	–	–	﹤0.01%	1004
2021 Q1	$6.97K	Sell	141 -200	-59%	-$9.61K	﹤0.01%	965
2020 Q4	$16.6K	Sell	341 -150	-31%	-$7.4K	﹤0.01%	767
2020 Q3	$24.6K	Hold	491	–	–	﹤0.01%	604
2020 Q2	$25.1K	Buy	491 +350	+248%	+$17K	﹤0.01%	581
2020 Q1	$6.17K	Hold	141	–	–	﹤0.01%	795
2019 Q4	$7.08K	Hold	141	–	–	﹤0.01%	859
2019 Q3	$6.53K	Hold	141	–	–	﹤0.01%	860
2019 Q2	$6.1K	Hold	141	–	–	﹤0.01%	891
2019 Q1	$6.24K	Hold	141	–	–	﹤0.01%	899
2018 Q4	$6.12K	Hold	141	–	–	﹤0.01%	892
2018 Q3	$6.3K	Hold	141	–	–	﹤0.01%	930
2018 Q2	$5.64K	Hold	141	–	–	﹤0.01%	945
2018 Q1	$5.65K	Sell	141 -31	-18%	-$1.29K	﹤0.01%	930
2017 Q4	$7.4K	Hold	172	–	–	﹤0.01%	892
2017 Q3	$8.56K	Buy	+172	New	+$8.32K	﹤0.01%	872

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

RBC Europe's SNY Position: Q4 2021 in Review

RBC Europe sold out of Sanofi (SNY) in Q4 2021, closing a stake of 141 shares — an estimated $6.8K sold.

RBC Europe first reported a position in SNY in Q3 2017 and held it in 17 quarters. The position peaked at $25.1K in Q2 2020. 624 funds tracked by Wall St. Rank hold SNY as of Q4 2021.

RBC Europe reported no remaining Sanofi position as of Q4 2021 after selling out during the quarter.
RBC Europe sold 141 Sanofi shares in Q4 2021, an estimated $6.8K.
RBC Europe first reported a position in Sanofi in Q3 2017 and held it in 17 quarters.
RBC Europe's Sanofi position peaked at $25.1K in Q2 2020.
624 funds tracked by Wall St. Rank held Sanofi as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.